Eli Lilly and Company, UnitedHealth Group, and Tempus AI are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies engaged in the research, development, manufacture or distribution of medical products and services—ranging from pharmaceuticals and biotechnology to medical devices and healthcare facilities. Owning these stocks gives investors exposure to the performance and innovations of firms working on treatments, diagnostics or medical technologies. Their market value often fluctuates with regulatory approvals, clinical trial results, demographic trends and changes in healthcare policy. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
Shares of LLY traded up $15.45 during midday trading on Thursday, reaching $675.94. The stock had a trading volume of 4,904,396 shares, compared to its average volume of 4,113,128. The firm has a 50 day simple moving average of $767.52 and a 200-day simple moving average of $796.25. Eli Lilly and Company has a one year low of $623.78 and a one year high of $972.53. The firm has a market cap of $639.75 billion, a PE ratio of 44.18, a P/E/G ratio of 0.90 and a beta of 0.44. The company has a current ratio of 1.28, a quick ratio of 1.00 and a debt-to-equity ratio of 1.86.
Read Our Latest Research Report on LLY
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Shares of UNH stock traded down $2.08 during midday trading on Thursday, hitting $269.73. 8,987,478 shares of the company were exchanged, compared to its average volume of 12,128,290. UnitedHealth Group has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The firm's 50 day moving average price is $289.37 and its two-hundred day moving average price is $401.34. The firm has a market capitalization of $244.28 billion, a P/E ratio of 11.69, a PEG ratio of 1.69 and a beta of 0.43.
Read Our Latest Research Report on UNH
Tempus AI (TEM)
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Shares of NASDAQ:TEM traded up $0.54 during midday trading on Thursday, hitting $70.17. The stock had a trading volume of 11,396,125 shares, compared to its average volume of 12,517,905. The company's 50-day moving average price is $62.64 and its 200-day moving average price is $58.28. The company has a market capitalization of $12.15 billion, a P/E ratio of -59.13 and a beta of 4.98. The company has a quick ratio of 1.56, a current ratio of 1.54 and a debt-to-equity ratio of 2.58. Tempus AI has a fifty-two week low of $31.36 and a fifty-two week high of $91.45.
Read Our Latest Research Report on TEM
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Eli Lilly and Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.
While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access